Premier Fund Managers’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Sell
454,800
-7,000
-2% -$183K 1% 47
2026
Q1
$12.8M Buy
461,800
+25,000
+6% +$666K 0.91% 48
2025
Q4
$10.9M Buy
+436,800
New +$11M 0.63% 61
2016
Q2
Sell
-36,890
Closed -$1.05M 56
2016
Q1
$1.05M Hold
36,890
1.03% 44
2015
Q4
$1.15M Buy
+36,890
New +$1.16M 1.08% 45

Other funds holding PFE

Premier Fund Managers's PFE Position: Q2 2026 in Review

Premier Fund Managers reduced its Pfizer (PFE) stake by 1.5% in Q2 2026, selling an estimated $183K and leaving 454,800 shares worth $11.1M. The position accounts for 1% of the portfolio, ranked #47.

Premier Fund Managers first reported a position in PFE in Q4 2015 and has held it in 5 quarters since. The position peaked at $12.8M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Premier Fund Managers held 454,800 shares of Pfizer worth $11.1M as of Q2 2026.
  • Premier Fund Managers sold 7,000 Pfizer shares in Q2 2026, an estimated $183K.
  • Pfizer made up 1% of Premier Fund Managers's portfolio in Q2 2026, its #47 holding.
  • Premier Fund Managers first reported a position in Pfizer in Q4 2015 and has held it in 5 quarters since.
  • Premier Fund Managers's Pfizer position peaked at $12.8M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Premier Fund Managers's 13F filing for Q2 2026, filed 22 Jul 2026.